Login

VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners 00:10:00

Share On Facebook Share On Twitter

Daniel Yadegar is the Co-Founder and CMO of Newpath Management.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Casius Mining's Promising Gold Exploration in Ghana: Insights from James at the One-to-One Conference
00:10:00
Unlocking Urban Living: Mainstreet Equity's Bob Dhillon on 14,500 Apartment Units
00:10:00
Claudio Erba, AI and platform expert and visionary Founder & CEO of Docebo, elucidates the synergy achieved through integration.|Claudio is the founder and CEO of Docebo
00:10:00
Unlocking Growth in Midcaps and Small Caps: Insights from Mihir Vora | Mihir Vora - Chief Investment Officer, Trust Mutual Fund
00:10:00
With all of our stakeholders for your support and continued trust, Chenbro is able to grow constantly|CEO ,Chenbro Micom Co Ltd
00:10:00
Unveiling Enable's Executive Dashboard: Transforming Rebate Management for Strategic Growth
00:10:00
Assessing U.S. Bond Market Challenges and Economic Outlook | Piers Hillier, CIO ,  Royal London Asset Management.
00:10:00
"Building Billion-Dollar Companies: Insights from XPO Executive Chairman Brad Jacobs"
00:10:00
Exploration Plans for White Cliff Minerals' Projects
00:10:00
coming from being a woman in venture capital who adapted to this new career path|Amy Saper,Partner,Accel
00:10:00
Brian Jean on Alberta's Energy Future and Global Leadership
00:10:00
Biotech Company CEO Discusses CAM2038 on Stockholm Stock Exchange Listing Day | Fredrik Tiberg, CEO, Camurus AB.

© 2026 Nehu